Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 3, 2008, Pages 393-395

  Song, Hui ^a,b   Bao, Weiguo ^c   Wang, Haibin ^b   An, Guipeng ^b   Feng, Jinbo ^b   Wang, Rong ^b   Zhang, Yun ^b   An, Fengshuang ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Endothelial vasoactive substances; Essential hypertension; Felodipine

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN; FELODIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN DERIVATIVE; PROSTACYCLIN I2; THROMBOXANE A2; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; COLORIMETRY; CONTROLLED STUDY; DATA ANALYSIS; DRUG RELEASE; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; FITNESS; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; TREATMENT DURATION;

ANGIOTENSIN II; COLORIMETRY; DELAYED-ACTION PREPARATIONS; ENDOTHELINS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 39849090662     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.081     Document Type: Article

References (13)